Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update

Date: July 15, 2014
Pages: 34
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T56D607CEC0EN
Leaflet:

Download PDF Leaflet

Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update
Summary

Transgenomic, Inc. (Transgenomic) is a biotechnology company. The company offers medicine in cardiology, oncology, and inherited diseases through its molecular technologies. Its diagnostic tools include REVEAL kits, SURVEYOR scan mutation detection kits, and SURVEYOR nuclease kits. Transgenomic offers equipments, reagents and other consumables that help in clinical and research applications in molecular testing and cytogenetics. Its pharmacogenomics service segment provides pharmacogenomics research services supporting phase II and phase III clinical trials. The company‘s clinical laboratories segment offers genetic testing services for cardiology, neurology, mitochondrial disorders, and oncology. Transgenomic is headquartered in Omaha, Nebraska, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Transgenomic, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Transgenomic, Inc. Company Snapshot
Transgenomic, Inc. Company Overview
Key Information
Transgenomic, Inc. Pipeline Products and Clinical Trials Overview
Transgenomic, Inc. – Pipeline Analysis Overview
Key Facts
Transgenomic, Inc. - Major Products and Services
Transgenomic, Inc. Pipeline Products by Development Stage
Transgenomic, Inc. Pipeline Products Overview
BLOCker - Sequencing Assay
BLOCker - Sequencing Assay Product Overview
COLD-PCR Assay - Pancreatic Cancer
COLD-PCR Assay - Pancreatic Cancer Product Overview
Ice COLD-PCR And BLOCker-Sequencing Combination Kit - EGFR
Ice COLD-PCR And BLOCker-Sequencing Combination Kit - EGFR Product Overview
ICE COLD-PCR Assay - Colorectal Cancer
ICE COLD-PCR Assay - Colorectal Cancer Product Overview
ICE COLD-PCR Assay - Lung Cancer
ICE COLD-PCR Assay - Lung Cancer Product Overview
LabChip MultiDx - ACE Kit BRAF V600
LabChip MultiDx - ACE Kit BRAF V600 Product Overview
LabChip MultiDx - ACE Kit EGFR Exons 19 & 21
LabChip MultiDx - ACE Kit EGFR Exons 19 & 21 Product Overview
NRAS Cancer Genetic Marker Test
NRAS Cancer Genetic Marker Test Product Overview
TP53 Cancer Genetic Marker Test
TP53 Cancer Genetic Marker Test Product Overview
Transgenomic, Inc. - Key Competitors
Transgenomic, Inc. - Key Employees
Transgenomic, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Transgenomic, Inc., Recent Developments
May 15, 2014: John D. Thompson Joins Transgenomic's Board of Directors
May 07, 2014: Transgenomic Reports First Quarter 2014 Financial Results
Mar 19, 2014: Dr. Michael A. Luther Joins Transgenomic's Board of Directors
Mar 12, 2014: Transgenomic Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Jan 16, 2014: Transgenomic Files Application for The NASDAQ Capital Market Listing and Board Approves Reverse Stock Split Ratio
Nov 18, 2013: Transgenomic Appoints Stephen R. Miller as Senior Vice President and General Manager of Patient Testing Business Unit
Nov 06, 2013: Transgenomic Reports Third Quarter 2013 Financial Results
Oct 23, 2013: Transgenomic Announces Presentation of MD Anderson ICE COLD-PCR Clinical Data at 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oct 15, 2013: PDI and Transgenomic, Inc. Partner to Commercialize Personalized Medicine Molecular Diagnostic Test
Sep 30, 2013: Transgenomic Announces Executive Changes
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Transgenomic, Inc., Key Facts
Transgenomic, Inc. Pipeline Products and Clinical Trials Overview
Transgenomic, Inc. Pipeline Products by Equipment Type
Transgenomic, Inc. Pipeline Products by Indication
Transgenomic, Inc., Key Facts
Transgenomic, Inc., Major Products and Services
Transgenomic, Inc. Number of Pipeline Products by Development Stage
Transgenomic, Inc. Pipeline Products Summary by Development Stage
BLOCker - Sequencing Assay - Product Status
BLOCker - Sequencing Assay - Product Description
COLD-PCR Assay - Pancreatic Cancer - Product Status
COLD-PCR Assay - Pancreatic Cancer - Product Description
Ice COLD-PCR And BLOCker-Sequencing Combination Kit - EGFR - Product Status
Ice COLD-PCR And BLOCker-Sequencing Combination Kit - EGFR - Product Description
ICE COLD-PCR Assay - Colorectal Cancer - Product Status
ICE COLD-PCR Assay - Colorectal Cancer - Product Description
ICE COLD-PCR Assay - Lung Cancer - Product Status
ICE COLD-PCR Assay - Lung Cancer - Product Description
LabChip MultiDx - ACE Kit BRAF V600 - Product Status
LabChip MultiDx - ACE Kit BRAF V600 - Product Description
LabChip MultiDx - ACE Kit EGFR Exons 19 & 21 - Product Status
LabChip MultiDx - ACE Kit EGFR Exons 19 & 21 - Product Description
NRAS Cancer Genetic Marker Test - Product Status
NRAS Cancer Genetic Marker Test - Product Description
TP53 Cancer Genetic Marker Test - Product Status
TP53 Cancer Genetic Marker Test - Product Description
Transgenomic, Inc., Key Employees
Transgenomic, Inc., Other Locations

LIST OF FIGURES

Transgenomic, Inc. Pipeline Products by Equipment Type
Transgenomic, Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: